YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Aarti Drugs
Aarti Drugs
BSE: 524348NSE: AARTIDRUGSISIN: INE767A01016

23rd-Jun-2021 21:24Source: BSE

Aarti Drugs - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Pursuant to Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we inform you that the Company has issued Duplicate share certificates in lieu of original share certificates

Board Meeting (Aarti Drugs)

Meeting Date

Remark

2021-07-27

Quarterly Results

Sections